Cargando…
Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation
Dexmedetomidine (DEX) is an anesthetic that is widely used in the clinic, and it has been reported to exhibit paradoxical effects in the progression of multiple solid tumors. In this study, we sought to explore the mechanism by which DEX regulates hepatocellular carcinoma (HCC) progression underlyin...
Autores principales: | Chen, Peng, Luo, Xiaojun, Dai, Guanqi, Jiang, Yuchuan, Luo, Yue, Peng, Shuang, Wang, Hao, Xie, Penghui, Qu, Chen, Lin, Wenyu, Hong, Jian, Ning, Xue, Li, Aimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080602/ https://www.ncbi.nlm.nih.gov/pubmed/32632241 http://dx.doi.org/10.1038/s12276-020-0461-6 |
Ejemplares similares
-
Inflammatory microenvironment of fibrotic liver promotes hepatocellular carcinoma growth, metastasis and sorafenib resistance through STAT3 activation
por: Jiang, Yuchuan, et al.
Publicado: (2021) -
Identification of Gene Signatures for Diagnosis and Prognosis of Hepatocellular Carcinomas Patients at Early Stage
por: Gan, Xiaoning, et al.
Publicado: (2020) -
Hepatic Stellate Cell Modulates the Immune Microenvironment in the Progression of Hepatocellular Carcinoma
por: Wang, Pei-Wen, et al.
Publicado: (2022) -
Hepatic stellate cell activation and senescence induced by intrahepatic microbiota disturbances drive progression of liver cirrhosis toward hepatocellular carcinoma
por: Liu, Boyuan, et al.
Publicado: (2022) -
CCN1/Cyr61 enhances the function of hepatic stellate cells in promoting the progression of hepatocellular carcinoma
por: Li, Zhi-Qiang, et al.
Publicado: (2018)